3 New Strong Buy Ratings from Top-Rated Analysts: 08/11/2026

Here’s a peek at the latest picks from our Strong Buy Stocks from Top Wall Street Analysts screener:

• Figs (FIGS): 29% sales growth powers direct-to-consumer disruptor
• CVS Health (CVS): Healthcare giant's Aetna recovery fuels 32% upside 
• Western Digital (WDC): A-rated stock with $900 max price forecast

P.S. Get more alerts like this daily … Try WallStreetZen Premium.

A note from our sponsors...

Please read the offering circular at invest.modemobile.com. This is a paid advertisement for Mode Mobile's Regulation A+ Offering.

1. Figs (NYSE: FIGS)

This medical apparel purveyor sells directly to healthcare professionals through its online platform, bypassing traditional medical supply stores. This direct-to-consumer model is driving strong engagement and margin expansion, with the company posting impressive quarterly results that sent shares surging over 25%.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $14.26 — get current quote

Max 1-year forecast: $22.00

Why we're watching:

• FIGS has solid, bullish coverage among the analysts we track, with 3 Strong Buy, 1 Buy, and 2 Hold recommendations. See all recommendations here
• For example, Barclays researcher Adrienne Yih (a top 3% rated analyst) maintained her Strong Buy rating with a price target suggesting the stock could see greater than 40% upside in the coming year. 
• Better still, BTIG researcher Robert Drbul (a top 14% rated analyst) attributed the quarter's strong results — headlined by 29% sales growth and expanding margins — to broad-based category strength, international momentum, and higher purchase frequency, maintaining his Strong Buy with a price target representing over 50% upside from current levels.
• Industry ranking context: FIGS is currently the #3 highest-rated stock in the Apparel Manufacturing industry, which has an Industry Rating of A.
• Zen Ratings highlights: FIGS earns an overall A rating, which amounts to a Strong Buy recommendation. Stocks with this rating represent the elite top 5% of all 4,600+ stocks tracked based on a rigorous 115-factor fundamental review.
• Component Grades: FIGS stands out with an A for Financials, reflecting exceptional profitability metrics and balance sheet health, while maintaining solid Bs for Growth and Sentiment, positioning the company well for continued appreciation in the direct-to-consumer healthcare apparel space. See all 7 Component Grades here

2. CVS Health (NYSE: CVS)

Not just CVS Pharmacy! This company owns CVS Caremark and Aetna, creating a vertically integrated healthcare ecosystem spanning retail pharmacy, pharmacy benefits management, and health insurance. The company's Aetna recovery paired with strong operational execution positions CVS for sustained growth, though 2027 PBM headwinds warrant monitoring.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $95.70 — get current quote

Max 1-year forecast: $126.00

Why we're watching:

• CVS has strong, bullish coverage among the analysts we track, with 10 Strong Buy and 5 Buy recommendations. See all recommendations here
• For example, UBS researcher Kevin Caliendo (a top 15% rated analyst) recently maintained his Strong Buy rating with a price target implying greater than 30% upside potential.
• Morgan Stanley researcher Erin Wright (a top 7% rated analyst) also recently raised her price target, noting that managed care stocks have been "grinding higher" based on lower utilization trends and predicting that MCOs could see an average EPS upside of 45% as a result of AI tailwinds across revenue and expense levers.
• Industry ranking context: CVS is currently the #3 highest-rated stock in the Healthcare Plan industry, which has an Industry Rating of A.
• Zen Ratings highlights: CVS earns an overall A rating, which is equal to a Strong Buy recommendation. Stocks in this topmost tier have historically delivered nearly 30% annual returns, soundly beating the S&P.
• Component Grades: CVS demonstrates balanced strength with solid Bs across Growth, Momentum, Sentiment, and Safety, indicating a well-rounded healthcare giant with sustainable competitive advantages and diversified revenue streams across its integrated care model. See all 7 Component Grades here

3. Western Digital (NASDAQ: WDC)

The memory sector is experiencing robust growth driven by AI data center demand, and this company is one of the main players supplying that demand with a tremendous backlog that has analysts raising their price targets left and right.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $434.30 — get current quote

Max 1-year forecast: $900.00

Why we're watching:

• WDC has strong, bullish coverage among the analysts we track, with 9 Strong Buy, 4 Buy, and 2 Hold recommendations. See all recommendations here
• For example, Citigroup researcher Asiya Merchant (a top 1% rated analyst) recently maintained her Strong Buy rating with a price target suggesting the stock could see greater than 70% upside in the coming year. 
• Even more bullish, Rosenblatt researcher Kevin Cassidy (a top 1% rated analyst) maintained his Strong Buy with a price target suggesting 84.20% upside potential, citing favorable market conditions and strong operational performance driving innovation and market share.
• Recent earnings demonstrated execution strength: EPS of $18.65 beat estimates by 0.43% with 28.47% year-over-year growth, while revenue of $11.77B exceeded expectations by 6.25% with 58.25% YoY growth.
• Industry ranking context: WDC is currently the #5 highest-rated stock in the Computer Hardware industry, which has an Industry Rating of C.
• Zen Ratings highlights: WDC earns an overall A rating, which amounts to a Strong Buy recommendation. Stocks with this rating represent the elite top 5% of all 4,600+ stocks tracked based on a rigorous 115-factor fundamental review.
• Component Grades: WDC excels with an A for Financials, reflecting exceptional profitability with a 93.8% profit margin, while maintaining solid Bs for Growth and Momentum, positioning the company to capitalize on the ongoing memory market recovery and AI-driven storage demand. See all 7 Component Grades here

What to Do Next?

• 77 Best Stocks NOW! >
• Options Trading with the Zen Ratings >
• 2 New Stocks to Buy from Steve Reitmeister >

Want to get in touch? Email us at news@wallstreetzen.com.